| Literature DB >> 17553138 |
Silvia Akerreta1, Rita Yolanda Cavero, María Isabel Calvo.
Abstract
BACKGROUND: An ethnobotanical and medical study was carried out in the Navarre Pyrenees, an area known both for its high biological diversity and its cultural significance. As well as the compilation of an ethnopharmacological catalogue, a quantitative ethnobotanical comparison has been carried out in relation to the outcomes from other studies about the Pyrenees. A review of all drugs used in the area has also been carried out, through a study of the monographs published by the institutions and organizations responsible for the safety and efficacy of medicinal plants (WHO, ESCOP, and the E Commission of the German Department of Health) in order to ascertain the extent to which the Navarre Pyrenees ethnopharmacology has been officially evaluated.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17553138 PMCID: PMC1904192 DOI: 10.1186/1746-4269-3-26
Source DB: PubMed Journal: J Ethnobiol Ethnomed ISSN: 1746-4269 Impact factor: 2.733
Figure 1Location of the area studied in Europe and in Navarra. • Visited villages Bioclimates Blank area: Temperate oceanic Random dotted area: Temperate oceanic sub-mediterranean Aggregately dotted area: Mediterranean pluviseasonal.
List of Pharmaceutic Categories.
| 1 | Cardiovascular system and haematology | Hypertension, cardiovascular diseases... |
| 2 | Dermatology | Warts, wounds, spots, burns... |
| 3 | Endocrinology, reproductive system, liver and gall bladder | Menstrual pain, reproductive system disorders.... |
| 4 | Gastrointestinal tract | Stomach ache, diarrhoea... |
| 5 | Joints and rheumatism | Rheumatism, tendons and joints troubles, osteoarthritis, muscular pains... |
| 6 | Infectious diseases, fever, anti-inflammatory and immunostimulating treatment | Infectious diseases, fever, anti-inflammatory and immunostimulating treatment |
| 7 | Neurology and psychiatry | Tranquillizer, stimulating... |
| 8 | Respiratory tract | Cold, bronchitis, asthma... |
| 9 | Urinary tract | Diuretic, depurative, prostate troubles, renal calculus... |
| 10 | Ears, nose, throat, mouth and ophthalmology | Sore throat, earache, eyes problems, toothaches,... |
| 11 | Other traditional applications | Foot odour, 'old diseases' and other advice to bring health and good luck. |
| 12 | Veterinary uses | Animal disorders |
Comparison of results of ethnobotanical studies of various Pyrenean regions.
| Region [a] | Locationb | Extension (km2) | Population | Flora | MPc | MP/km2 | NId | MP/Ie | EIf |
| Pallars [41-43] | E | 2530 | 18800 | 1500 | 437 | 0.17 | 264 | 1.7 | 29.1 |
| Cerdanya [46] | E | 1086 | 23000 | 1600 | 234 | 0.21 | 155 | 1.5 | 15 |
| Alt Empordà [40,44] | E | 178 | 41300 | 1650 | 300 | 1.68 | 195 | 1.53 | 18 |
| Cerdanya i Conflent [45] | E | 2200 | 45000 | - | 225 | 0.10 | 208 | 1.03 | - |
| Pirineo oscense [5,48] | C | 15671 | 222000 | 2656 | 553 | 0.035 | - | - | 20.82 |
| Pirineo navarro* | W | 2200 | 7800 | 1822 | 92 | 0.042 | 88 | 1.04 | 5.05 |
a Reference
b Location in Pyrenees: C: central Pyrenees; E: eastern Pyrenees; W: western Pyrenees.
c Number of medicinal plants cited
d Number of informants
e Number of medicinal plants cited per informant
f Ethnobotanicity index
* Present study
Medicinal plants with Monograph (revision on WHO, ESCOP and Commission E)
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |||||||||||||||||||||||
| E | S | W | E | S | W | E | S | W | E | S | W | E | S | W | E | S | W | E | S | W | E | S | W | E | S | W | E | S | W | E | S | W | ||
| ■ | ||||||||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■ | ■ | |||||||||||||||||||||||||||||||||
| ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | * | |||||||||||||||||||||||||
| □ | □ | □ | ||||||||||||||||||||||||||||||||
| ■ | ■ | |||||||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■ | ■ | ■ | ||||||||||||||||||||||||||||||||
| ■ | ■ | |||||||||||||||||||||||||||||||||
| Centaurium erythraea ssp. majus majus | ■ | ■ | ||||||||||||||||||||||||||||||||
| ■ | ■ | ■ | ■ | ■ | ■ | |||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■ | ■ | |||||||||||||||||||||||||||||||||
| ■ | ■ | |||||||||||||||||||||||||||||||||
| ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | |||||||||||||||||||||||
| ■ | ■ | ■ | * | |||||||||||||||||||||||||||||||
| ■ | ■ | ■ | * | |||||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■ | ■ | ■ | ||||||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■ | ■ | □ | ||||||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■ | ■ | |||||||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■, | ■ | |||||||||||||||||||||||||||||||||
| ■ | ■ | ■ | ■ | ■ | ■ | |||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■ | ■ | ■ | ■ | |||||||||||||||||||||||||||||||
| Sambucus nigra | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ||||||||||||||||||||||||||
| ■ | ■ | ■ | ■ | ■ | ■ | |||||||||||||||||||||||||||||
| ■ | ■ | ■ | ■ | |||||||||||||||||||||||||||||||
| ■ | ■ | ■ | ■ | ■ | ||||||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
| ■a | ||||||||||||||||||||||||||||||||||
| ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | |||||||||||||||||||||||||||
| ■ | ||||||||||||||||||||||||||||||||||
a: 1: Cardiovascular system and haematology; 2: Dermatology; 3: Endocrinology, reproductive system liver and gall bladder; 4: Gastrointestinal tract; 5: Joints and rheumatism; 6: Infectious diseases, fever, anti-inflammatory and inmunostimulant; 7: Neurology and psychiatry; 8: Respiratory tract; 9: Urinary tract; 10: Ear, nose, throat, mouth and ophthalmology; 11: Other traditional applications. 12: Veterinary uses.
b: E: Commission E; S: ESCOP; W: WHO (): Positive Monograph; () negative Monograph; (■): It exists a Monograph but for other therapeutic category; (□): It exists Monograph for this therapeutic application, but the organ floral does not coincide.
* For veterinary use there is not Monograph.